Published in J Comp Pathol on January 01, 1999
Toxicology of choroid plexus: special reference to metal-induced neurotoxicities. Microsc Res Tech (2001) 1.24
Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus. Cerebellum (2012) 1.00
The Balance between Life and Death of Cells: Roles of Metallothioneins. Biomark Insights (2007) 0.89
Immunocytochemical localization of metallothionein and its relation to doxorubicin toxicity in transgenic mouse heart. Am J Pathol (2000) 0.83
Peripheral nerve and brain differ in their capacity to resolve N,N-diethyldithiocarbamate-mediated elevations in copper and oxidative injury. Toxicology (2010) 0.79
Age-dependent increase of brain copper levels and expressions of copper regulatory proteins in the subventricular zone and choroid plexus. Front Mol Neurosci (2015) 0.76
Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol (2000) 2.35
Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol (2000) 2.34
Total-body potassium in hypertension patients during prolonged diuretic therapy. Lancet (1972) 2.09
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods (2001) 2.01
A simple post-embedding system for the rapid demonstration of tissue antigens under the electron microscope. Histochem J (1983) 1.95
Best Practice No 176: Updated recommendations for HER2 testing in the UK. J Clin Pathol (2004) 1.90
Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol (1994) 1.88
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.72
High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology (2003) 1.64
Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol (2000) 1.62
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia (2006) 1.62
Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol (1994) 1.52
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine (2007) 1.46
Hepatic organelle pathology in dogs with congenital portosystemic shunts. J Vet Intern Med (1992) 1.40
Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells. Biochem J (1979) 1.26
Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology (2005) 1.25
Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Br J Cancer (1995) 1.22
Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer (1990) 1.22
HER2 testing in the UK: further update to recommendations. J Clin Pathol (2008) 1.22
Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax (1996) 1.22
Studies on the mast cell triggering action of certain artificial histamine liberators. Int Arch Allergy Appl Immunol (1973) 1.19
Histogenesis of haemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome. J Clin Pathol (1985) 1.17
Human wound contraction: collagen organization, fibroblasts, and myofibroblasts. Plast Reconstr Surg (1998) 1.16
Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function. Cell Tissue Res (1999) 1.15
An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations. Histochem J (1987) 1.14
Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch (1997) 1.12
Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation. Cancer (1992) 1.10
Alpha-actinin in nemaline bodies in congenital nemaline myopathy: immunological confirmation by light and electron microscopy. Neuromuscul Disord (1995) 1.10
Use of monoclonal antihapten antibodies for immunolocalisation of tissue antigens. J Clin Pathol (1981) 1.09
Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid (2001) 1.08
A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine (2008) 1.08
Copper toxicosis in Bedlington terriers. Vet Rec (2000) 1.08
Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol (1990) 1.07
Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. Br J Cancer (2008) 1.06
Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol (1989) 1.05
The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine (2005) 1.04
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells Mol Dis (2005) 1.04
Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma. J Clin Pathol (2001) 1.03
Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison. Am J Surg Pathol (1994) 1.02
Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology (1993) 1.02
Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding. Endocrinology (1984) 1.01
Evaluation of automated silver-enhanced in situ hybridization (SISH) for detection of HER2 gene amplification in breast carcinoma excision and core biopsy specimens. Histopathology (2009) 1.00
Thrombomodulin as a marker of vascular and lymphatic tumours. Histopathology (1996) 0.98
Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit. Gastroenterology (2001) 0.96
Metal compound intensification of the electron-density of diaminobenzidine. J Histochem Cytochem (1983) 0.96
The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis. Acta Neuropathol (1993) 0.95
Metallothionein expression in human breast cancer. Br J Cancer (1995) 0.95
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine (2001) 0.95
Topical thrombin and control of wound haematoma. Lancet (1977) 0.94
Factor VIII as a marker of endothelial cells in follicular carcinoma of the thyroid. J Clin Pathol (1983) 0.93
Copper toxicosis and tolerance in the rat. III. Intracellular localization of copper in the liver and kidney. Exp Mol Pathol (1985) 0.93
DNA and enzyme studies on chorionic villi for use in antenatal diagnosis. Clin Chim Acta (1984) 0.92
Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing. J Clin Pathol (2004) 0.92
Prophylactic HPV vaccination for women over 18 years of age. Vaccine (2009) 0.92
Synchronous duodenal neuroendocrine tumours in von Recklinghausen's disease--a case report of co-existing gangliocytic paraganglioma and somatostatin-rich glandular carcinoid. Histopathology (1987) 0.90
Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Res Treat (1994) 0.90
The effect of excess dietary copper on the liver and kidney of the male rat. J Comp Pathol (1980) 0.90
Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma. Thorax (1985) 0.89
Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol (1995) 0.89
Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch (1994) 0.89
Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain. Neuropathol Appl Neurobiol (1996) 0.88
A system for accurate immunolocalization of Tamm-Horsfall protein in renal biopsies. Histochem J (1985) 0.87
Molybdenum-associated pituitary endocrinopathy in sheep treated with ammonium tetrathiomolybdate. J Comp Pathol (2004) 0.87
Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM (2003) 0.87
Copper toxicosis and tolerance in the rat. I--Changes in copper content of the liver and kidney. J Pathol (1985) 0.87
The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact? J Clin Pathol (2009) 0.87
Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity. J Neurol Sci (1993) 0.86
Cellular mechanisms of toxicity and tolerance in the copper-loaded rat. I. Ultrastructural changes in the liver. Liver (1988) 0.85
High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology (1999) 0.85
An investigation of the optimal conditions for the in vivo production of immunologically sensitised rat mast cells. J Immunol Methods (1979) 0.85
Cellular mechanisms of toxicity and tolerance in the copper-loaded rat. II. Pathogenesis of copper toxicity in the liver. Exp Mol Pathol (1989) 0.85
Immunogold electron-microscopic localisation of calpain I in skeletal muscle of rats. Cell Tissue Res (1986) 0.85
Glandular duodenal carcinoid--a somatostatin rich tumour with neuroendocrine associations. J Clin Pathol (1984) 0.85
Immunohistochemical detection of metallothionein. Methods Enzymol (1991) 0.85
Acceptability and feasibility of a community approach to asthma management: the Neighborhood Asthma Coalition (NAC). J Asthma (1996) 0.85
Idiopathic hepatic fibrosis in 15 dogs. Vet Rec (1993) 0.85
A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection. J Infect (1996) 0.85
Immunocytochemical diagnosis of early myocardial ischaemic/hypoxic damage. Forensic Sci Int (1989) 0.84
The effect of excess dietary copper on plasma enzyme activity and on the copper content of the blood of the male rat. J Comp Pathol (1980) 0.84
Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary. Gynecol Oncol (1988) 0.84
E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch (1997) 0.84
HER2 testing, adjuvant trastuzumab use and results. Our experience in South Wales. Clin Oncol (R Coll Radiol) (2010) 0.84
Role of calcium chelation in high-temperature antigen retrieval at different pH values. J Pathol (1997) 0.83
In situ correlation of synthesis and storage of parathormone in parathyroid gland disease. J Pathol (1993) 0.83
Metallothionein and copper in liver disease with copper retention--a histopathological study. J Pathol (1989) 0.82
Histochemical and immunocytochemical evaluation of copper and metallothionein in the liver and kidney of copper-loaded rats. J Pathol (1990) 0.82
Histological demonstration of immunoreactive zinc metallothionein in liver and ileum of rat and man. Histochem J (1985) 0.82
Ultimobranchial body nests in human fetal thyroid: an autopsy, histological, and immunohistochemical study in relation to solid cell nests and mucoepidermoid carcinoma of the thyroid. J Pathol (1993) 0.82
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. Purinergic Signal (2011) 0.82
Parathyroid hyperplasia in tertiary hyperparathyroidism: a pathological and immunohistochemical reappraisal. Histopathology (1992) 0.82
The protective role of metallothionein in copper overload: I. Differential distribution of immunoreactive metallothionein in copper-loaded rat liver and kidney. Chem Biol Interact (1991) 0.81
Effect of goitrogen administration on the circadian rhythm of serum thyroid stimulating hormone in the rat. Acta Endocrinol (Copenh) (1981) 0.81
Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology (1989) 0.81
Evaluation of histochemical methods for the detection of copper overload in rat liver. Liver (1987) 0.81
Non-deleterious dinitrophenyl (DNP) hapten labelling of antibody protein. Preparation and properties of some short-chain DNP imidoesters. J Immunol Methods (1984) 0.81